Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Hongjian Tang
Observed name:
Tang, Hongjian
Institution:
Kantonsspital Winterthur
Observed institution:
Kantonsspital Winterthur
ORCID:
0000-0001-7812-2575
Observed ORCID:
0000-0001-7812-2575
OpenAlex ID:
A5090537777
Stereotactic Body Radiotherapy for High-Risk Prostate Cancer: A Systematic Review
2021
·
Robert Foerster
, Daniel Rudolf Zwahlen
, et al.
·
Cancers
·
48
PDF
Stereotactic Radiotherapy after Radical Prostatectomy in Patients with Prostate Cancer in the Adjuvant or Salvage Setting: A Systematic Review
2022
·
Christina Schröder
, Hongjian Tang
, et al.
·
Cancers
·
29
PDF
Re-irradiation to the prostate using stereotactic body radiotherapy (SBRT) after initial definitive radiotherapy – A systematic review and meta-analysis of recent trials
2024
·
Christina Schröder
, Hongjian Tang
, et al.
·
Clinical and Translational Radiation Oncology
·
10
PDF
Converting between the International Prostate Symptom Score (IPSS) and the Expanded Prostate Cancer Index Composite (EPIC) urinary subscales: modeling and external validation
2024
·
Paul Windisch
, Ivo Becker
, et al.
·
BMC Urology
·
6
PDF
Dose-Volume Histogram Parameters and Quality of Life in Patients with Prostate Cancer Treated with Surgery and High-Dose Volumetric-Intensity-Modulated Arc Therapy to the Prostate Bed
2023
·
Luca Hanke
, Hongjian Tang
, et al.
·
Cancers
·
6
PDF
Converting between the International Prostate Symptom Score (IPSS) and the Expanded Prostate Cancer Index Composite (EPIC) Urinary Subscales: Modeling and External Validation
2023
·
Paul Windisch
, Ivo Becker
, et al.
·
medRxiv
·
1
PDF
农村生活污水治理中单一厌氧池工艺升级改造
2026
·
Chen Zhihua
, Guan Shixin
, et al.
·
DOAJ (DOAJ: Directory of Open Access Journals)
484: SAKK 16/18: QA and interim safety of immune-modulatory RT in resectable stage III(N2) NSCLC
2024
·
Tobias Finazzi
, Lisa Holer
, et al.
·
Radiotherapy and Oncology
Show more works
View as search
Works count:
9
Citation count:
99
H-index:
5
I10-index:
2
Year
Topic
Type